Last reviewed 2026-04-22 · How we verify

Daesiho-tang

Gachon University Gil Oriental Medical Hospital · FDA-approved active Small molecule

Daesiho-tang is a Small molecule drug developed by Gachon University Gil Oriental Medical Hospital. It is currently FDA-approved for Respiratory conditions and digestive disorders (traditional use). Also known as: DSHT, Elsion Granule.

Daesiho-tang is a traditional herbal medicine formulation that modulates immune and inflammatory responses to support respiratory and digestive health.

Daesiho-tang is a traditional herbal medicine formulation that modulates immune and inflammatory responses to support respiratory and digestive health. Used for Respiratory conditions and digestive disorders (traditional use).

At a glance

Generic name	Daesiho-tang
Also known as	DSHT, Elsion Granule
Sponsor	Gachon University Gil Oriental Medical Hospital
Modality	Small molecule
Therapeutic area	Traditional/Herbal Medicine
Phase	FDA-approved

Mechanism of action

As a polyherbal decoction used in Oriental medicine, Daesiho-tang likely works through multiple bioactive compounds that collectively reduce inflammation, support immune function, and promote gastrointestinal and respiratory wellness. The exact molecular mechanisms have not been fully characterized in Western pharmacological terms, as this is a traditional medicine preparation rather than a single-target synthetic drug.

Approved indications

Respiratory conditions and digestive disorders (traditional use)

Common side effects

No common side effects on file.

Key clinical trials

A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial - (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Daesiho-tang CI brief — competitive landscape report
Daesiho-tang updates RSS · CI watch RSS
Gachon University Gil Oriental Medical Hospital portfolio CI

Frequently asked questions about Daesiho-tang

What is Daesiho-tang?

Daesiho-tang is a Small molecule drug developed by Gachon University Gil Oriental Medical Hospital, indicated for Respiratory conditions and digestive disorders (traditional use).

How does Daesiho-tang work?

Daesiho-tang is a traditional herbal medicine formulation that modulates immune and inflammatory responses to support respiratory and digestive health.

What is Daesiho-tang used for?

Daesiho-tang is indicated for Respiratory conditions and digestive disorders (traditional use).

Who makes Daesiho-tang?

Daesiho-tang is developed and marketed by Gachon University Gil Oriental Medical Hospital (see full Gachon University Gil Oriental Medical Hospital pipeline at /company/gachon-university-gil-oriental-medical-hospital).

Is Daesiho-tang also known as anything else?

Daesiho-tang is also known as DSHT, Elsion Granule.

What development phase is Daesiho-tang in?

Daesiho-tang is FDA-approved (marketed).

Manufacturer: Gachon University Gil Oriental Medical Hospital — full pipeline
Therapeutic area: All drugs in Traditional/Herbal Medicine
Indication: Drugs for Respiratory conditions and digestive disorders (traditional use)
Also known as: DSHT, Elsion Granule

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing